TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology - Netherlands
doi 10.1016/j.eururo.2011.07.011
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Canadian Urological Association Journal
Urology
2017English

Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2009English

Circulating Tumor Cell Analysis in Patients With Progressive Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Circulating Tumor Cells in Patients With Castration-Resistant Prostate Cancer Baseline Values and Correlation With Prognostic Factors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

The First Experience in Using Abiraterone Acetate in Patients With Castration-Refractory Prostate Cancer

Andrologia i Genital'naa Hirurgia
SurgeryReproductive MedicineUrology
2015English

Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis

IJU Case Reports
2018English

Partial Response of Liver Metastases Treated With Abiraterone in Castration-Resistant Prostate Cancer: A Case Report

Oncology Letters
Cancer ResearchOncology
2013English

AR Splice Variants in Circulating Tumor Cells of Patients With Castration‐resistant Prostate Cancer: Relation With Outcome to Cabazitaxel

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy